Page 44 - Development Facility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ucore Chairman & CEO Provides Strategic Update to Shareholders: Taking Action Today to Secure Tomorrow Provided $1.9 million of funding to IMC for the further advancement of the RapidSX™ technology for commercial deployment; including a $1-million tranche transferred on April 26, 2021Allocated funding for an Independent Evaluation of RapidSX™ technology for the separation of REEs – scheduled for completion in Summer 2021Allocated $750,000 to further ongoing specific business-development activities and initial … Provided $1.9 million of funding to IMC for the further advancement of the...

The shock of COVID-19 is definitely exposing those vulnerabilities. A new World Trade Organization (WTO) report, Strengthening Africa’s capacity to trade, addresses the disruptions to trade due to the pandemic and outlines the ways the international body is working to encourage trade flows on the continent. As LDCs, countries get additional international support with development assistance and with trade, and 33 of the 46 LDCs today are in Africa. What does the report say of African LDCs and global trade? What support are countries being given to best weather this COVID-19 storm? Declines a...

More from AP

Innovation Metals Corp. Announces Execution of RapidSX Separation Technology Testing Agreement with Rare-Earth Producer Innovation Metals Corp. is pleased to announce the execution of a binding Technology Testing Agreement with a leading, US-allied-sourced rare-earth element producer for a program utilizing the Company’s proprietary RapidSX™ separation technology . The purpose of the TTA is to generate empirical data for the evaluation of the RapidSX technology for the separation of the specific mixed-REE concentrate produced by … Innovation Metals Corp. (“ IMC ” or the “ Company ...

Apr 27, 2021 10:55am Sanofi will close a facility in Malvern, Pennsylvania, that packages and distributes investigational medical products. (Pixabay) Sanofi will divest an R&D facility in Malvern, Pennsylvania, where investigational medical products are packaged and distributed as the French pharmaceutical giant undergoes a strategic transformation. A spokeswoman for Sanofi confirmed April 27 that the Great Valley site will close by the end of September. “With recent changes in Sanofi’s R&D portfolio, we’ve seen decreased activity at Great Valley and anticipate a continued decl...